Concepts (159)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pulmonary Embolism | 7 | 2020 | 231 | 3.640 |
Why?
|
| Diagnostic Errors | 5 | 2022 | 158 | 2.070 |
Why?
|
| Intensive Care Units | 6 | 2023 | 429 | 2.010 |
Why?
|
| Critical Illness | 5 | 2022 | 327 | 1.950 |
Why?
|
| Problem Solving | 4 | 2023 | 54 | 1.500 |
Why?
|
| Physical Examination | 3 | 2018 | 151 | 1.420 |
Why?
|
| Clinical Competence | 5 | 2019 | 807 | 1.380 |
Why?
|
| Sepsis | 3 | 2019 | 351 | 1.350 |
Why?
|
| Shock, Septic | 2 | 2019 | 108 | 1.160 |
Why?
|
| Echocardiography | 5 | 2020 | 969 | 1.150 |
Why?
|
| Thinking | 2 | 2018 | 35 | 1.140 |
Why?
|
| Anti-Bacterial Agents | 4 | 2022 | 808 | 1.080 |
Why?
|
| Internal Medicine | 4 | 2019 | 364 | 1.020 |
Why?
|
| Teaching Rounds | 2 | 2018 | 25 | 1.000 |
Why?
|
| Acute Disease | 4 | 2020 | 856 | 0.960 |
Why?
|
| Decision Making | 3 | 2019 | 680 | 0.890 |
Why?
|
| Humans | 42 | 2023 | 92304 | 0.770 |
Why?
|
| Education, Medical | 4 | 2020 | 246 | 0.750 |
Why?
|
| Antimicrobial Stewardship | 1 | 2022 | 24 | 0.740 |
Why?
|
| Epidemics | 1 | 2022 | 33 | 0.740 |
Why?
|
| Medication Errors | 1 | 2021 | 39 | 0.730 |
Why?
|
| Ketosis | 1 | 2021 | 9 | 0.720 |
Why?
|
| Health Personnel | 1 | 2023 | 224 | 0.720 |
Why?
|
| Critical Care | 4 | 2019 | 398 | 0.720 |
Why?
|
| Aminopyridines | 1 | 2021 | 45 | 0.700 |
Why?
|
| Isocitrate Dehydrogenase | 1 | 2021 | 57 | 0.700 |
Why?
|
| Triazines | 1 | 2021 | 55 | 0.700 |
Why?
|
| Diagnosis, Differential | 7 | 2019 | 1594 | 0.660 |
Why?
|
| Publications | 1 | 2020 | 27 | 0.650 |
Why?
|
| Thiamine Deficiency | 1 | 2019 | 4 | 0.630 |
Why?
|
| Acidosis, Lactic | 1 | 2019 | 10 | 0.630 |
Why?
|
| Patient Safety | 2 | 2020 | 220 | 0.630 |
Why?
|
| Drug-Related Side Effects and Adverse Reactions | 1 | 2021 | 205 | 0.620 |
Why?
|
| Ehlers-Danlos Syndrome | 1 | 2019 | 9 | 0.620 |
Why?
|
| Shock | 1 | 2019 | 44 | 0.620 |
Why?
|
| Cardiologists | 1 | 2019 | 5 | 0.620 |
Why?
|
| Syncope | 2 | 2016 | 35 | 0.610 |
Why?
|
| Vena Cava, Superior | 1 | 2019 | 60 | 0.600 |
Why?
|
| Out-of-Hospital Cardiac Arrest | 1 | 2020 | 94 | 0.600 |
Why?
|
| Intention | 1 | 2019 | 52 | 0.590 |
Why?
|
| Catheters | 1 | 2019 | 86 | 0.590 |
Why?
|
| Range of Motion, Articular | 1 | 2019 | 169 | 0.580 |
Why?
|
| Enzyme Inhibitors | 1 | 2021 | 651 | 0.580 |
Why?
|
| Patient Care | 1 | 2019 | 102 | 0.570 |
Why?
|
| Medical Staff, Hospital | 2 | 2019 | 109 | 0.550 |
Why?
|
| Vertebrobasilar Insufficiency | 1 | 2017 | 18 | 0.550 |
Why?
|
| Vena Cava Filters | 1 | 2018 | 86 | 0.550 |
Why?
|
| Dizziness | 1 | 2017 | 26 | 0.540 |
Why?
|
| Point-of-Care Systems | 1 | 2018 | 147 | 0.540 |
Why?
|
| Head Movements | 1 | 2017 | 40 | 0.540 |
Why?
|
| Streptococcal Infections | 1 | 2017 | 55 | 0.530 |
Why?
|
| Clinical Clerkship | 1 | 2018 | 120 | 0.520 |
Why?
|
| Marketing of Health Services | 1 | 2016 | 15 | 0.520 |
Why?
|
| Ventricular Outflow Obstruction | 1 | 2016 | 22 | 0.510 |
Why?
|
| Renal Dialysis | 1 | 2019 | 340 | 0.500 |
Why?
|
| Students, Medical | 2 | 2018 | 433 | 0.490 |
Why?
|
| Brain Diseases | 1 | 2017 | 186 | 0.480 |
Why?
|
| Echocardiography, Transesophageal | 1 | 2018 | 358 | 0.480 |
Why?
|
| Education, Medical, Graduate | 2 | 2018 | 411 | 0.480 |
Why?
|
| Patient Care Team | 2 | 2018 | 296 | 0.480 |
Why?
|
| Hemodynamics | 1 | 2019 | 757 | 0.470 |
Why?
|
| Delivery of Health Care | 1 | 2020 | 436 | 0.470 |
Why?
|
| Psychotic Disorders | 1 | 2017 | 207 | 0.470 |
Why?
|
| Inpatients | 2 | 2018 | 331 | 0.460 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2021 | 815 | 0.460 |
Why?
|
| Health Promotion | 1 | 2016 | 168 | 0.460 |
Why?
|
| Social Media | 1 | 2016 | 100 | 0.450 |
Why?
|
| Acute Kidney Injury | 1 | 2019 | 324 | 0.450 |
Why?
|
| Hospitalization | 1 | 2019 | 926 | 0.410 |
Why?
|
| Thrombolytic Therapy | 3 | 2020 | 252 | 0.390 |
Why?
|
| Asthma | 1 | 2019 | 1003 | 0.350 |
Why?
|
| Quality of Health Care | 1 | 2014 | 390 | 0.340 |
Why?
|
| Hypertension | 1 | 2016 | 763 | 0.340 |
Why?
|
| Retrospective Studies | 5 | 2022 | 9679 | 0.320 |
Why?
|
| Medical Overuse | 2 | 2020 | 36 | 0.310 |
Why?
|
| Resuscitation | 2 | 2020 | 111 | 0.300 |
Why?
|
| Internship and Residency | 4 | 2019 | 1083 | 0.290 |
Why?
|
| Ventricular Dysfunction, Right | 2 | 2019 | 151 | 0.270 |
Why?
|
| Hospitals | 2 | 2020 | 313 | 0.260 |
Why?
|
| Prostatic Neoplasms | 1 | 2016 | 1771 | 0.230 |
Why?
|
| Cohort Studies | 2 | 2023 | 2976 | 0.230 |
Why?
|
| Prognosis | 2 | 2023 | 3872 | 0.210 |
Why?
|
| Observational Studies as Topic | 1 | 2023 | 52 | 0.210 |
Why?
|
| Risk Assessment | 2 | 2020 | 2369 | 0.190 |
Why?
|
| Female | 9 | 2021 | 47894 | 0.190 |
Why?
|
| Aged | 4 | 2021 | 19952 | 0.190 |
Why?
|
| Middle Aged | 6 | 2019 | 27043 | 0.190 |
Why?
|
| Medication Reconciliation | 1 | 2021 | 6 | 0.190 |
Why?
|
| Pharmacists | 1 | 2021 | 35 | 0.180 |
Why?
|
| Histiocytic Sarcoma | 1 | 2021 | 8 | 0.180 |
Why?
|
| United States Agency for Healthcare Research and Quality | 1 | 2020 | 6 | 0.170 |
Why?
|
| Male | 6 | 2021 | 43924 | 0.170 |
Why?
|
| Causality | 1 | 2020 | 81 | 0.160 |
Why?
|
| Patient Acuity | 1 | 2019 | 36 | 0.160 |
Why?
|
| Organ Dysfunction Scores | 1 | 2019 | 30 | 0.160 |
Why?
|
| Lactates | 1 | 2019 | 37 | 0.160 |
Why?
|
| Thiamine | 1 | 2019 | 9 | 0.160 |
Why?
|
| Risk Factors | 2 | 2020 | 5705 | 0.160 |
Why?
|
| Contraceptives, Oral | 1 | 2019 | 48 | 0.150 |
Why?
|
| Diagnosis | 1 | 2018 | 18 | 0.150 |
Why?
|
| Lactic Acid | 1 | 2019 | 99 | 0.150 |
Why?
|
| Chest Pain | 1 | 2019 | 46 | 0.150 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2019 | 2683 | 0.150 |
Why?
|
| Community-Acquired Infections | 1 | 2019 | 65 | 0.150 |
Why?
|
| Dyspnea | 1 | 2019 | 80 | 0.150 |
Why?
|
| Treatment Failure | 1 | 2019 | 288 | 0.150 |
Why?
|
| Time-to-Treatment | 1 | 2019 | 129 | 0.140 |
Why?
|
| Stroke Volume | 1 | 2020 | 499 | 0.140 |
Why?
|
| Electronic Health Records | 1 | 2021 | 364 | 0.140 |
Why?
|
| Pneumonia | 1 | 2019 | 187 | 0.140 |
Why?
|
| Terminology as Topic | 1 | 2018 | 224 | 0.140 |
Why?
|
| Vena Cava, Inferior | 1 | 2018 | 140 | 0.130 |
Why?
|
| Hospitalists | 1 | 2019 | 141 | 0.130 |
Why?
|
| Qualitative Research | 1 | 2019 | 325 | 0.130 |
Why?
|
| Angiography, Digital Subtraction | 1 | 2017 | 97 | 0.130 |
Why?
|
| Radiography, Thoracic | 1 | 2019 | 331 | 0.130 |
Why?
|
| Bias | 1 | 2017 | 137 | 0.130 |
Why?
|
| Direct-to-Consumer Advertising | 1 | 2016 | 1 | 0.130 |
Why?
|
| Professionalism | 1 | 2016 | 25 | 0.130 |
Why?
|
| Thrombosis | 1 | 2019 | 312 | 0.130 |
Why?
|
| Cerebral Angiography | 1 | 2017 | 211 | 0.130 |
Why?
|
| Immunoglobulins | 1 | 2017 | 139 | 0.130 |
Why?
|
| Syndrome | 1 | 2017 | 449 | 0.130 |
Why?
|
| Sex Factors | 1 | 2019 | 1095 | 0.130 |
Why?
|
| Artificial Intelligence | 1 | 2020 | 356 | 0.130 |
Why?
|
| Fluid Therapy | 1 | 2016 | 53 | 0.130 |
Why?
|
| Patient Discharge | 1 | 2019 | 339 | 0.130 |
Why?
|
| Family Practice | 1 | 2016 | 84 | 0.120 |
Why?
|
| Feasibility Studies | 1 | 2018 | 800 | 0.120 |
Why?
|
| Teaching | 1 | 2016 | 146 | 0.120 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2017 | 278 | 0.120 |
Why?
|
| Brain Neoplasms | 1 | 2021 | 801 | 0.120 |
Why?
|
| Registries | 1 | 2020 | 904 | 0.120 |
Why?
|
| Ultrasonography | 1 | 2016 | 707 | 0.110 |
Why?
|
| Spinal Fusion | 1 | 2017 | 237 | 0.110 |
Why?
|
| Atrioventricular Block | 1 | 2013 | 27 | 0.100 |
Why?
|
| Recurrence | 1 | 2016 | 1180 | 0.100 |
Why?
|
| Heart Ventricles | 1 | 2018 | 795 | 0.100 |
Why?
|
| Cognition | 1 | 2017 | 603 | 0.100 |
Why?
|
| Practice Guidelines as Topic | 1 | 2019 | 1073 | 0.100 |
Why?
|
| Prospective Studies | 2 | 2018 | 4469 | 0.100 |
Why?
|
| Magnetic Resonance Imaging, Cine | 1 | 2013 | 165 | 0.100 |
Why?
|
| Cost-Benefit Analysis | 1 | 2014 | 490 | 0.090 |
Why?
|
| Age Factors | 1 | 2016 | 1902 | 0.090 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2013 | 221 | 0.090 |
Why?
|
| Physician-Patient Relations | 1 | 2016 | 630 | 0.090 |
Why?
|
| Electrocardiography | 1 | 2013 | 507 | 0.090 |
Why?
|
| Adult | 3 | 2021 | 27535 | 0.080 |
Why?
|
| United States | 1 | 2020 | 7346 | 0.070 |
Why?
|
| Treatment Outcome | 1 | 2017 | 8727 | 0.050 |
Why?
|
| Meningitis | 1 | 2021 | 22 | 0.040 |
Why?
|
| Fatal Outcome | 1 | 2021 | 299 | 0.040 |
Why?
|
| Monocytes | 1 | 2021 | 223 | 0.040 |
Why?
|
| Patients | 1 | 2019 | 106 | 0.040 |
Why?
|
| Residence Characteristics | 1 | 2019 | 204 | 0.030 |
Why?
|
| Wisconsin | 1 | 2016 | 44 | 0.030 |
Why?
|
| Antibodies, Antinuclear | 1 | 2013 | 91 | 0.030 |
Why?
|
| Curriculum | 1 | 2016 | 582 | 0.020 |
Why?
|
| Heart Rate | 1 | 2013 | 502 | 0.020 |
Why?
|